MET amplification(amp) is a major resistance mechanism to osimertinib-From 2017 ASCO POSTER
作者头像
Moonshadow 2017-06-23
转载 443 0

上一篇：2017年国际大会发言汇总
下一篇：Differential Crizotinib Efficacy among ROS1 Fusion Partners in ROS1-Positive Non-Small-Cell Lung Can
相关推荐
暂无
暂无相关推荐
评论 (0)
loading...
    回到顶部